Search companies

Live

Tuesday, 17 November 2026 · 581 Summaries Today

S&P/ASX 200 · 8,883.20 (-1.79%)

Emyria Revenue Triples As Sydney Clinic Opens And US Strategy Advances

Emyria Limited (EMD) · Health care

EMD: $0.039 -4.88% · MC: $31M

Emyria reported record quarterly revenue of approximately $1 million, up from approximately $0.5 million in the same quarter last year, and opened its first Sydney clinic, expanding its network to four states with capacity for up to 90 dosing sessions a week. It received initial Department of Veterans’ Affairs patient approvals, with more than 40 referrals in its pipeline, and appointed former US Veterans Affairs Secretary Dr David Shulkin as a strategic adviser to support US opportunities. The company also said it is in late-stage discussions with an international pharmaceutical sponsor, but no agreement has been finalised.

Source announcements: 2026-10-29 09:50 to 2026-10-29 09:50 Sydney time
Story updated 2026-10-29 09:54 Sydney time
SourcesSeptember 2026 Quarterly Activities Report and Appendix 4C
Comments